Showing posts with label Small Animal Imaging Market. Show all posts
Showing posts with label Small Animal Imaging Market. Show all posts

Tuesday, October 1, 2019

Small Animal Imaging Market will be US$ US$ 2.7 bn by 2020

Small animal imaging market comprises the devices and reagents used for preclinical imaging of rats and mice for drug development and gene expression studies. These devices are similar to imaging modalities used for diagnostic purposes in humans, however due to the smaller size are generally referred as micro devices such as micro-MRI, micro-SPECT and others. Anatomical, molecular and functional analysis in pre-imaging can provide valuable information to understand the activity of pharmaceutical compounds in preclinical or phase I stage. Such visualization and analysis help and support supporting studies evaluating APIs activity as well as its safety and toxicity.
Being a non-invasive technique, longitudinal studies are possible in preclinical imaging with accurate and detailed analysis. The global small animal imaging market has been studied from three main perspectives: by devices, by reagents, and by application areas. Various devices in the preclinical imaging market include micro-computed tomography (CT), micro-magnetic resonance imaging (MRI), micro-positron emission tomography (PET), single positron emission computed tomography (SPECT), multimodal imaging, optical imaging, micro-ultrasound imaging and micro-photoacoustic tomography (PAT).
The contrast reagents market comprises reagents used in CT, MRI, nuclear imaging, optical imaging and ultrasound imaging technologies. The market with respect to major application areas is studied for oncology, cardiology, autoimmune diseases, neurology & psychiatry and others. Since the inception of the market micro-CT and micro-MRI devices have well established themselves in the market. However the multimodal and optical imaging market are the fastest growing in the global small animal imaging market. In the contrast reagents market optical imaging reagents is the fastest growing market owing to increasing number of gene expression studies. In optical imaging reagents, fluorescent-labeled contrast agents have shown to be useful and safe alternatives to radiotracers in preclinical imaging studies.
The preclinical imaging market has gone through myriad technological advancements and increase in research funding which has exponentially grown the market. Prominent factors driving the global small animal imaging market include growing installation base of multimodal and optical imaging market across the globe. Additionally the increasing demand for preclinical CROs market in Asia Pacific and other developing parts of the world have also boosted the growth in last one decade. High development cost leading to slow adoption rate and restricted accessibility to nuclear imaging reagents are among the few restraints to the market.
Over the years the reagents market is expected to grow at a rapid pace due to frequent purchase, high shelf life of devices limiting the frequent purchase and growing number of reagent manufacturers. Companies should focus on improving MRI based multimodal imaging devices such as PET/MRI devices is likely to open extensive growth opportunities in the forthcoming years.
Geographically the market is largely dominated by North America followed by Europe due to frequent product launches, increasing preclinical research activities and high adoption rate for expensive devices. Asia Pacific and Rest of the World are among the fastest growing market due to growing number of CROs and increasing industry based funding for conducting pharmaceutical based preclinical researches.
The global small animal imaging market has consolidated in the past few years. Some of the prominent players profiled in the report include Agilent Technologies, Inc., Aspect Imaging, Bruker Corporation, TriFoil Imaging, Inc., LI-COR Biosciences, Inc., Miltenyi Biotec GmbH, Perkin Elmer, Inc., Promega Corporation, Siemens AG, SCANCO Medical AG and Targeson, Inc.

Wednesday, October 10, 2018

Small Animal Imaging Market to Reach an Opportunity of US$ US$2.7 bn by the End of 2020

The vendor landscape of the global market for small animal imaging features an intense level of competition due to the presence of numerous well-established players, according to a recent market research report by Transparency Market Research. The rising set of growth opportunities in the field of veterinary medicine has compelled companies to focus on bringing innovations in the field of production. Companies are also focused on R&D activities so as to develop technologically more advanced imaging technologies to gain a larger hold on the market.
Report Overview @ https://www.transparencymarketresearch.com/small-animal-imaging.html

For improved sales, companies could plough more resources into MRI-based multimodal imaging devices such as PET or MRI as the demand for such devices has been rising at a promising pace in the past few years. Bruker Corporation, Agilent Technologies, Inc., TriFoil Imaging, Inc., LI-COR Biosciences, Inc., Aspect Imaging, and Miltenyi Biotec GmbH are some of the leading companies in the market.
small-animal-imaging-marketAccording to the report, the global market for small animal imaging will exhibit an impressive 8.6% CAGR over the period between 2014 and 2020, rising to a revenue valuation of US$ US$2.7 bn by 2020. Geographically, the markets in regions such as Asia Pacific, Middle East and Africa, and Latin America are expected to present the most lucrative set of growth opportunities over the report’s forecast period. The rising numbers of pharmaceutical and biopharmaceutical preclinical researches in these regions will contribute to the promising set of growth opportunities.
Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2469

Rise in Numbers of Gene Expression Studies to Boost Market
One of the key factors expected to drive the market is the vast rise in investment in the development of new diagnostic and therapeutic measures aimed at the various ailments in small animals. The market is also expected to benefit majorly from the rising focus on research activities aimed at further understanding regarding gene expression and its link with a number of diseases in small animals. The market has also significantly benefitted from the rising installation of optical and multimodal imaging devices across specialty veterinary clinics across the globe.
The rising numbers of contract research organizations in Asia Pacific and a promising rise in research activities aimed at the treatment and diagnosis of diseases in small animals has also resulted in a promising rise in demand for small animal imaging devices globally. Similar trend is also likely to prevail in other regional markets with emerging economies.
Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2469

High Cost Involved in Manufacturing Could Hamper Market Growth
Despite mostly promising growth opportunities, the market could be restrained to a certain degree in the next few years. One of the toughest challenges faced by the market is the high cost involved in the manufacturing of imaging devices for small animals. Owing to this factor, the market fails to target a potentially vast set of growth opportunities in emerging economies, where the consumer is cost-conscious and could prefer other diagnostic and treatment measures due to the cost factor.